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Abstract: Age-related macular degeneration (AMD) is characterized primarily by degeneration of the macular 
retinal pigment epithelium (RPE) that secondarily leads to cell death of photoreceptors and impaired central 
vision. Hallmarks of AMD are accumulation of lysosomal lipofuscin and extracellular drusen, which indicate 
impaired proteolysis in RPE cells. Cellular proteostasis is strongly regulated by molecular chaperones such as 
Hsp70 and proteasomal and autophagic clearance systems. We have recently shown that autophagy receptor 
SQSTM1/p62 binds irreversibly to proteasome inhibitor–induced perinuclear protein aggregates and undergoes 
autophagic clearance in RPE cell cultures. Revealing decreased autophagy, SQSTM1/p62 accumulates in 
macular area of donor AMD patient samples. In this study, we show that Hsp70 binds reversibly to proteasome 
inhibitor–induced perinuclear protein aggregates and does not become degraded by autophagy in ARPE-19 
cells. Our observation reveals new opportunities to use a cytoprotective Hsp70 as a therapy target in the 
prevention of RPE cell degeneration and development of AMD.  
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Introduction 
 
        Age-related macular degeneration (AMD), the leading 
cause of irreversible blindness in the Western world, is 
characterized primarily by degeneration of the macular 
retinal pigment epithelium (RPE) [1]. RPE damage leads 
secondarily to cell death of photoreceptors (rods and cones) 
and impaired vision. The cells of RPE are exposed to 
chronic oxidative stress originated mainly from three 
sources: (i) high levels of oxygen consumption, (ii) exposure 
to lipid peroxidation products derived from the ingestion of 
photoreceptor outer segments, and (iii) exposure to constant 
light stimuli. Chronic oxidative stress may evoke misfolding 
and aggregation of proteins especially during aging. Heat 
shock proteins (HSPs) attempt to repair the misfolding 
damage. If this fails, soluble proteins become ubiquitinated 
and targeted into proteasomes for degradation [2, 3]. 
Increased levels of HSPs have been observed in RPE cells 
with accumulated lipofuscin and in retina samples of AMD 
patients [4, 5]. Moreover, proteasomal activity declines 
during aging, which leads to aggregation of oxidized and 
ubiquitinated proteins, as has been documented to happen in 
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RPE [6, 7]. Impaired proteasomal clearance in RPE cells 
induces selective macroautophagy (referred to as autophagy) 
[7, 8], which is the most prevalent form of autophagy. It 
involves formation of a double-membrane structure 
(autophagosome) and engulfment of cytoplasmic proteins, 
lipids and damaged organelles [9]. Thereafter, 
autophagosomes fuse with primary lysosomes, and their 
contents become degraded by lysosomal enzymes [10].  
        Cellular homeostasis is largely dependent on the quality 
control of proteins, which is called proteostasis [11]. Hsp70 
is one of the key chaperone proteins in the regulation of 
proteostasis together with proteasomal and autophagic 
clearance [11]. SQSTM1/p62 (Sequestosome 1) is the best-
characterized and most ubiquitously expressed autophagy 
adaptor that connects proteasomal clearance with autophagy 
[7, 8, 12-15]. We have previously shown that SQSTM1/p62 
binds irreversibly to perinuclear protein aggregates and 
undergoes autophagic clearance [7]. On the other hand, 
alleviation of autophagy is usually accompanied by 
accumulation of SQSTM1/p62, especially on areas that are 
rich of ubiquitin-stained protein aggregates, as recently 
reported in AMD patients [7, 8]. 
 
 
 
Figure 1. Representative transmission electron micrographs on 
untreated control ARPE-19 cells (upper) and cells exposed to 5 µM 
MG-132 for 24 h. Aggregates are indicated by white and nuclei by 
black arrows. Scale bar = 3 µm. 
 
        When proteasomal clearance becomes inhibited in RPE 
cells, Hsp70 accumulates in same protein aggregates with 
SQSTM1/p62 [7, 16]. SQSTM1/p62 rather than Hsp70 is 
considered to be a marker for autophagic activity [7, 8]. In 
this study, we show that Hsp70 binds in a reversible manner 
to proteasome inhibitor–induced perinuclear protein 
aggregates and does not become degraded by autophagy in 
ARPE-19 cells.  
 
Materials and methods 
 
        ARPE-19 cells originated from human retinal pigment 
epithelium were obtained from the American Type Culture 
Collection (ATCC). The cells were grown to confluence in a 
humidified 10% CO2 atmosphere at 37°C in Dulbecco’s 
MEM/Nut MIX F-12 (1:1) medium (Life Technologies, 
21331) containing 10% inactivated fetal bovine serum 
(Hyclone, SV30160-03), 100 units/ml penicillin, 100 µg/ml 
streptomycin (Lonza, DE17-602E), and 2 mM L-glutamine 
(Lonza, BE17-605E). In order to induce protein aggregates, 
the cells were exposed to 5 µM of MG-132 proteasome 
inhibitor (Calbiochem, 474790). Lysosomal function was 
disturbed by 50 nM of bafilomycin A1 (Sigma, B1793). 
Autophagy was activated with the AMPK (AMP-activated 
protein kinase) activator AICAR (5-Aminoimidazole-4-
carboxyamide ribonucleoside, Toronto Research Chemical, 
A611700) at 2 mM concentration or induced by starving the 
cells in serum-free medium. All exposures lasted for 24 
hours. 
 
Transmission electron microscopy 
 
        Cell culture samples were prefixed with 2.5% 
glutaraldehyde in 0.1 M phosphate buffer (pH 7.4) for 2 
hours at room temperature. After 15 minutes washing with 
0.1 M phosphate buffer, the cells were post-fixed in 1% 
osmium tetraoxide and 0.1 M phosphate buffer for 1 hour, 
and washed with phosphate buffer for 15 minutes prior to 
standard ethanol dehydration. Subsequently, the samples 
were infiltrated and embedded in LX-112 resin. 
Polymerization was carried out at 37°C for 24 h and at 60°C 
for 48 hours. The sections were examined with a JEM-2100F 
transmission electron microscope (Jeol) at 200 kV. 
 
Western blotting 
 
        For Western blotting, whole cell extracts containing 20 
µg of protein were run in 10% SDS-PAGE gels and then 
transferred to nitrocellulose membranes (Amersham 
Biosciences) using a semi-dry transfer apparatus (Bio-Rad 
Laboratories). Successful transfer of proteins from gels to 
membranes was monitored by Ponceau S staining (Sigma). 
The membranes were blocked in 0.3% Tween 20/PBS 
(phosphate-buffered saline) containing 3% fat-free dry milk 
for 1.5 hours at room temperature (RT). Subsequently, the 
membranes were incubated overnight at 4°C with a mouse 
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Figure 2. Transfections of ARPE-19 cells with pDendra2-hHsp70 (A and B) and with pDendra2-hp62 (C) constructs. After 24-hour 
transfections, cells were treated for 24 hours with bafilomycin (50 nM) and MG-132 (5 µM) (panel A) or with MG-132 alone (B and 
C). The pictures were taken at the moment of UV exposure within the zones drawn with a white line. White arrows indicate the 
spreading of red colour outside of the exposed spot. Zone diameter = 1 µm. 
 
monoclonal Hsp70 antibody (StressGen) or with a mouse 
monoclonal anti-α-tubulin (Sigma). Primary antibodies were 
diluted 1:5000 and 1:8000, respectively, in 0.3% Tween 
20/PBS containing 0.5% bovine serum albumin. After three 
10-minute washes with 0.3% Tween 20/PBS, the membranes 
were incubated for 2 hours at RT with horseradish 
peroxidase-conjugated secondary antibodies (Amersham 
Biosciences). Secondary antibodies were diluted 1:20 000 
for Hsp70 and 1:10 000 for α-tubulin in 0.3% Tween 
20/PBS containing 3% fat-free dry milk. Before detection, 
all membranes were washed as mentioned above. Protein-
antibody complexes were detected with an enhanced 
chemiluminescence method (Millipore). 
 
pDendra2-Hsp70 fusion plasmid construction 
 
        The functional open reading frame (ORF) of human 
Hsp70 A1A gene (NCBI Nucleotide accession no. 
NM_005345) was amplified from DNase-treated (DNase I, 
Roche) total RNA, which was extracted using the Eurozol 
reagent (Euroclone) from human ARPE-19 cells. RNA was 
reverse-transcribed by MultiScribe reverse transcriptase 
(Applied Biosystems), and Hsp70 cDNA was amplified with 
Phusion Hot start DNA polymerase (Finnzymes). Primers 
were 5'-ATA CTC GAG atA TGG CCA AAG CCG C 
(forward) and 5'-AAT AAG CTT gCT AAT CTA CCT CCT 
CAA TGG TG (reverse), containing target sites for 
restriction endonucleases XhoI and HindIII (italics) and 
stuffers (minuscules) for in-frame ligation. Sites for the 
initiation and termination of translation are in boldface. 
        Sticky ends for the amplified Hsp70 ORF as well as for 
the multiple cloning site of the vector pDendra2-C 
(Evrogen) [17] were produced with above-mentioned 
restriction endonucleases (MBI Fermentas). Ligated (T4 
DNA Ligase, Roche) DNA containing a fusion gene of 
Dendra2 and Hsp70 was transfected into competent DH5α 
E. coli cells, which were prepared using the protocol 
described by Inoue et al. [18] Following the bacterial 
growth, plasmids were purified as previously described [19]. 
Integrity of the construct, named pDendra2-hHsp70, was 
determined initially by the restriction endonuclease digestion 
analysis and finally by sequencing the junction sites and the 
entire inserted Hsp70 ORF. 
        The plasmid pDendra2-hp62 producing a fusion protein 
containing Dendra2 and human SQSTM1/p62, analogous to 
pDendra2-hHsp70 described above, was prepared as 
previously described [7]. Preliminarily, the structure and 
functionality of the fusion proteins were initially monitored 
using RT-PCR amplification of a 365-bp fragment flanking 
one junction and by Western hybridization with a Hsp70 
antibody (StressGen) detecting the fusion protein (not 
shown). 
 
Plasmid transfection and confocal microscopy 
 
        The pDendra2 fusion plasmids were transfected into 
subconfluent cultures of ARPE-19 cells using the ExGen500 
in vitro transfection reagent (MBI Fermentas) following 
manufacturer's instructions. In all transfection experiments 
for confocal microscopy, ExGen 500 in vitro Transfection 
Reagent (MBI Fermentas) was used according to the 
manufacturer’s protocol. ARPE-19 cells were cultured in 8-
well plates (µ-Slide, ibiTreat, tissue culture treated, Ibidi) to 
subconfluent density. Thereafter, the pDendra2 fusion 
plasmids containing 1 µg DNA per well were added, and the 
cells were incubated for 24 hours. Subsequently, the culture 
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Figure 3. Image from a representative western blot showing the expression of Hsp70 in control ARPE-19 cells and in cells exposed to 
5 µM of MG-132 and 50 of nM bafilomycin, together or alone for 24 hours. α-tubulin was used as a loading control. 
 
  
 
Figure 4. Image from a representative western blot showing the expression of Hsp70 protein in control ARPE-19 cells and in cells 
exposed to 5 µM of MG-132, 2 mM of AICAR, starvation or simultaneously to 5 µM of MG-132 and 2 mM of AICAR or starvation 
for 24 hours. α-tubulin was used as a loading control. 
 
medium was changed and MG-132 (5 µM) and bafilomycin 
(50 nM) were added for 24 hours. Transfected cells were 
exposed to UV radiation (405 nm), which changed the 
photo-switchable colour of Dendra2 from green to red. 
Fluorescent images were obtained with a Zeiss Axio 
Observer inverted microscope (40 × NA 1.3 or 63 × NA 1.4 
oil objectives) equipped with the Zeiss LSM 700 confocal 
module (Carl Zeiss). For live cell imaging, Zeiss XL-LSM 
S1 incubator with temperature and CO2 controls was 
utilized. ZEN 2009 software (Carl Zeiss) was used for image 
processing. 
 
Results 
 
        We recently documented that SQSTM1/p62, a shuttle 
protein between proteasomal and autophagic clearance, 
binds permanently in perinuclear aggregates and 
subsequently undergoes autophagic clearance [7]. Since 
Hsp70 binds to the same aggregates [16], we wanted to 
evaluate whether the binding of Hsp70 is a reversible or an 
irreversible process. First, ARPE-19 cells were exposed to 5 
µM concentration of MG-132 for 24 hours, which evoked  
strong formation of perinuclear protein aggregates (Fig. 1) 
[16]. Then pDendra2-hHsp70 fusion plasmid construct was 
transfected to the cells and confocal microscopy was used 
for live cell imaging. The movement of pDendra2-hHsp70 
fusion protein was evaluated after photo conversion (Fig. 2). 
We detected that Hsp70 protein moved from the converted 
area to other parts of the cell, which suggests that the 
binding of Hsp70 to protein aggregates is reversible. As a 
comparison, pDendra2-hp62 did not leave the exposed area 
(Fig. 2, panel C) [7]. 
        Bafilomycin is known to inhibit autophagy by 
preventing the fusion of autophagosomes with lysosomes 
[9]. To examine how bafilomycin affects the expression of 
Hsp70 protein in ARPE-19, the cells were treated either with 
50 nM of bafilomycin, 5 µM of MG-132 or both. Thereafter, 
total protein extracts were analysed for the expression of 
Hsp70 using the western blotting technique. In contrast to 
our previous observations with SQSTM1/p62 [7], ARPE-19 
cells treated with bafilomycin displayed no changes in 
Hsp70 protein levels (Fig. 3). When the cells were exposed 
simultaneously to both bafilomycin and MG-132, there was 
a significant increase in the amount of Hsp70 protein. A 
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similar increase in the levels of Hsp70 was seen in cells 
treated with MG-132 alone. This suggested that Hsp70 is not 
degraded by autophagy. 
        In order to confirm this hypothesis, possible effects of 
AICAR and serum starvation on the Hsp70 expression under 
MG-132 stimulation were studied. Induction of autophagy 
by either way did not change the Hsp70 protein levels (Fig. 
4). These results support the idea that Hsp70, in contrast to 
SQSTM1/p62, does not bind permanently to proteasome 
inhibitor–induced protein aggregates and does not undergo 
the autophagic clearance. 
 
Discussion 
 
        In the present study, we have shown that the best-
known molecular chaperone Hsp70 binds to perinuclear 
protein aggregates by a reversible mechanism under 
proteasome inhibition in human retinal ARPE-19 cells. We 
have recently shown using pDendra2-hLC3 
(MAP1LC3A/LC3) and pDendra2-hp62 (SQSTM1/p62) 
plasmids, with which localisation of the proteins in a cell can 
be detected at a desired time point, that both LC3 and 
SQSTM1/p62 disappeared via autophagic clearance in 
response to the inhibition of proteasomes and the induction 
of autophagy. The binding of SQSTM1/p62 protein to 
perinuclear aggregates was observed to be an irreversible 
process [7, 9]. In contrast to our previous results, we show 
here by pDendra2-hHsp70 fusion plasmid construction 
analyses that Hsp70 moves from protein aggregates during 
proteasome inhibition, indicating reversible binding of 
Hsp70 to protein aggregates. 
        Blocking the expression of SQSTM1/p62 rather than 
Hsp70 using mRNA silencing results in decreased 
autophagosome formation in ARPE-19 cells [7]. However, 
both of them had similar cytoprotective capacity under 
proteasome inhibition. Cytoprotection was obviously 
involved in the repairing chaperone function of Hsp70, while 
SQSTM1/p62 regulated the induction of autophagic 
clearance. Once autophagy was induced during proteasome 
inhibition, SQSTM1/p62 degradation also became 
accelerated. In this study, we have shown that the induction 
of autophagy by AICAR or by starvation, or the inhibition of 
autophagy by bafilomycin, did not change Hsp70 levels 
under proteasome inhibition. This indicates that Hsp70 is 
protected from autophagic clearance. 
        Hsp70 consists of two major functional domains; the 
amino-terminal domain that possesses the ATP/ADP binding 
site as well as the ATPase activity, and the carboxy-terminal 
domain, which contains the binding site for substrate 
peptides [20]. In the ATP-bound state, substrates can easily 
bind to and dissociate from Hsp70. When ATP is hydrolysed 
to ADP, the affinity of a substrate to Hsp70 becomes 
increased [21]. An important feature in the Hsp70’s cycle is 
that chaperone proteins have several co-chaperones that 
modulate substrate interactions. We found that Hsp70 binds 
in a reversible manner to proteasome inhibitor–induced 
protein aggregates. This process might be controlled by the 
ATP/ADP regulation cycle. Post-translational modifications 
of Hsp70 such as SUMOylation, ubiquitination or 
glycosylation may also control the binding activity of Hsp70 
to the client proteins in aggresomes and prevent its 
autophagic clearance [22-27]. There is evidence that in 
contrast to SQSTM1/p62, Hsp70 favours proteasomal 
clearance in certain stress conditions [26]. 
        Damage in cellular macromolecules accumulates during 
aging and tissue degeneration in postmitotic cells, such as 
RPE cells [3]. It has recently been proposed that declining 
heat shock response, reduced levels of HSPs, and the 
resultant loss of protein quality control may exacerbate 
protein damage during aging [28-31]. Molecular Hsp70 
chaperone therapy might be a new formulation strategy in 
the treatment of retinal pigment epithelium and AMD [32]. 
RPE cells are phagocytic and they can internalise 
extracellular material as occurs e.g. with photoreceptor outer 
segments during normal visual cycle. The shed 
photoreceptor outer segment particles are taken up by RPE 
via endocytic and phagocytic processes and degraded in 
lysosomes [3]. In aged RPE cells, however, lysosomal 
enzyme activity is decreased, which leads to harmful 
lipofuscin accumulation and reflects the severity of AMD 
[33]. In the Hsp70-based therapy, proteins should be 
targeted to lysosomes due to phagocytic process [34]. 
Interestingly, Hsp70 has been found in lysosomal fractions 
of RPE cells [4, 16]. It might be hypothesized that Hsp70 as 
a molecular chaperone keeps lysosomal enzymes 
functionally active, prevents lipofuscin accumulation in RPE 
cells and thereby suppresses the development of AMD [35]. 
Hsp70 has also anti-inflammatory capacity [36]. 
Inflammation is a central hallmark in the pathogenesis of 
AMD. Therefore, Hsp70 might also prevent inflammatory 
signalling in RPE cells. The present data importantly show 
that Hsp70 is protected from lysosomal clearance system 
and thus provide opportunity to develop its use in protein, 
drug or laser therapy for the prevention of AMD. 
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